NewslettersHematopoiesis NewsUncategorizedDelayed Administration of Ixazomib Modifies the Immune Response and Prevents Chronic Graft-versus-Host DiseaseBy Justin.choi - September 23, 2021020Investigators aimed to modify the immune response in the long term after allogeneic bone marrow transplantation by using the proteasome inhibitor ixazomib at the late stages of the post-transplant period.[Bone Marrow Transplantation] 7992332 AAAAAAAA items 1 apa 0 default asc 1 167101 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article